Consequently, IgE deficiency can reduce atherosclerotic inflammation and promote M2 macrophage polarization; therefore, targeting IgE therapy for atherosclerosis is an attractive therapeutic route (67). This evidence concerns the gene IGHE and atherosclerosis.